SELANK 5mg

Description

Selank 5mg – Research Peptide

Other sizes. This is the 5mg vial. The same compound is also supplied as a 10mg vial.

Selank 5mg is a high-purity, research-grade synthetic peptide supplied for use in controlled laboratory environments. This compound is provided to support scientific investigation involving peptide signaling, neurochemical pathways, and related biochemical mechanisms.

Selank is a synthetic heptapeptide derived from the naturally occurring tetrapeptide tuftsin. It has appeared in scientific literature examining central nervous system peptide signaling and molecular interactions relevant to neurotransmitter systems.

Selank 5mg is intended strictly for in-vitro laboratory research and analytical study. This material is not approved for human or veterinary use and must not be used in clinical, diagnostic, or therapeutic applications.

What Is Selank?

Selank is a synthetic heptapeptide analog structurally related to tuftsin. In published scientific literature, Selank has been examined within experimental models involving central nervous system peptide signaling and neurochemical pathways.

Research discussions involving Selank have explored interactions with several molecular systems, including:

• GABA-related signaling pathways
• Neurotrophic factor pathways including BDNF
• Peptide-mediated immune signaling mechanisms
• Stress-related neurochemical pathways
• Central nervous system peptide activity
• Neurotransmitter signaling models
• Central nervous system peptide interactions
• Molecular pathways related to stress signaling
• Neurotrophic factor expression pathways

These areas remain subjects of ongoing laboratory investigation.

Selank 5mg – Research Supply Specifications

• Research-grade synthetic peptide
• Purity standard: 99%+ (analytical testing)
• Supplied in 5mg lyophilized format for laboratory handling
• Third-party analytical verification for identity and purity
• Canada-based fulfillment
• Batch-level quality control

Purity & Quality Assurance

ExoLabz provides research peptides manufactured to high analytical standards. Selank 5mg undergoes independent third-party testing to verify peptide identity and purity.

Researchers may perform additional analytical verification if required for their work. If validated third-party testing confirms a verified purity discrepancy, ExoLabz provides refund and testing reimbursement in accordance with company policy.

Important Legal Notice

For Research Purposes Only

Selank 5mg is supplied strictly for laboratory research and analytical use.

This compound is not intended for human consumption, veterinary use, clinical research involving human subjects, therapeutic use, or diagnostic applications.

This product has not been evaluated or approved by Health Canada, the U.S. Food and Drug Administration (FDA), or any other regulatory authority.

By purchasing, the buyer confirms that the material will be handled only by qualified professionals and used solely for lawful laboratory research purposes.

Compound identity and specification

Identity data for Selank, published so the material can be checked against an independent record rather than taken on trust. The formula, mass and registry number below are verified against PubChem and can be looked up directly.

Analytical note — Selank. Three of seven residues are proline, which produces conformational peak broadening, and the lysine and arginine make the peptide strongly basic with no acidic residue to offset them. Ion-pairing additive in the mobile phase is doing real work on this one.

Identity references The molecular formula, molecular mass and CAS registry number above are taken from the PubChem record linked in the table, not from a supplier datasheet, so every figure can be checked against an independent source in one click. Sequences are given as reported in the peptide literature, in the one-letter or three-letter convention as appropriate, with any non-standard residue named in full. Where a compound exists in more than one form — a free peptide and a metal complex, a fragment and its parent protein, a modified and an unmodified analog — the form supplied is the one identified here, and the mass on the certificate of analysis is what distinguishes it.

Research Literature

Peer-reviewed studies involving this compound and its class. All findings listed are from in vitro, cell culture or animal models and are provided for scientific reference only. This product is supplied for laboratory research and is not approved for human consumption, clinical, or veterinary use.

• Semenova TP, et al. Eksp Klin Farmakol. 2009;72(4):6-8. In male Wistar rats pretreated with the serotonin synthesis inhibitor PCPA, measured serotonin turnover in brainstem and neocortex. Source · PMID 19803361
• Kolomin T, et al. Regul Pept. 2011;170(1-3):18-23. In mouse spleen, measured expression of inflammation-related genes following administration. Source · PMID 21609736
• Volkova A, et al. Front Pharmacol. 2016;7:31. In rat frontal cortex, measured expression of 84 GABAergic and neurotransmission-related genes 1-3 hours after administration, against diazepam. Source · PMID 26924987

The third-party report for this material is published on this page, and every certificate we hold is collected on the certificates of analysis page.

Related Research Compounds

Browse more compounds in Neuropeptides, or view the full research peptide catalogue.

• KISSPEPTIN-10 5mg
• DSIP 5mg
• SELANK 10mg
• SEMAX 10mg